I think we can be a little more optimistic today. Awor’s statement was from before CRISPR was invented. The advent of CRISPR is amazing. Its utilisation and further development are progressing at a rapid speed. Clinical application has already started. There is a lot of money behind it. It’s been coupled with the use of mRNA technologies. And, of course, with mRNA delivering the first COVID-19 vaccinations, this is also all the rage. It’s a fortunate development for us.
Obviously, this means very little if we don’t know what the problem is. There is a lot of work for us to do to understand our condition and identify therapeutic targets. And, obviously, there is also a lot of progress to make for science for genome/epigenome editing or similar interventions to become “normal”. But compared to 2009, technologies that may help us in the future are actually under development and actively being tested in much more simple conditions. That’s a positive, even if it is still a long shot.